Lumilis, Jiocel .
HRN: 26-64-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2025
CEFUROXIME 750MG (VIAL)
02/07/2025
02/14/2025
INTRAVENOUS
300 Mg IVTT
Every 8 Hours
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes